[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 4, Issue 2 (Int J Mol Cell Med 2015) ::
Int J Mol Cell Med 2015, 4(2): 67-86 Back to browse issues page
p38 MAPK and PI3K/AKT signalling cascades in Parkinson’s disease
Saurabh Kumar Jha 1, Niraj Kumar Jha 1, Rohan Kar 1, Rashmi Kumar Ambasta 1, Pravir Kumar * 2
1- Molecular Neuroscience and Functional Genomics Laboratory, Department of Biotechnology, Delhi Technological University (Formerly DCE), Delhi, India., Molecular Neuroscience and Functional Genomics Laboratory, Department of Biotechnology, Delhi Technological University (Formerly DCE), Delhi, India.
2- Molecular Neuroscience and Functional Genomics Laboratory, Department of Biotechnology, Delhi Technological University (Formerly DCE), Delhi, India., Molecular Neuroscience and Functional Genomics Laboratory, Department of Biotechnology, Delhi Technological University (Formerly DCE), Delhi, India. , Pravir.Kumar@tufts.edu
Abstract:   (5037 Views)
Parkinson's disease (PD) is a chronic neurodegenerative condition which has the second largest incidence rate among all other neurodegenerative disorders barring Alzheimer's disease (AD). Currently there is no cure and researchers continue to probe the therapeutic prospect in cell cultures and animal models of PD. Out of several factors contributing to PD prognosis, the role of p38 MAPKs (mitogen-activated protein (MAP) kinase) and PI3K/AKT signalling module in PD brains is crucial because impaired balance between the pro-apoptotic and anti-apoptotic pathways trigger unwanted phenotypes such as microglia activation, neuroinflammation, oxidative stress, and apoptosis. These factors continue challenging the brain homeostasis in initial stages thereby essentially assisting the dopaminergic (DA) neurons towards progressive degeneration in PD. Neurotherapeutics against PD shall then be targeted against the misregulated accomplices of the p38 and PI3K/AKT cascades. In this review, we have outlined many such established mechanism involving the p38 MAPK and PI3K/AKT pathways which can offer therapeutic windows for rectification of aberrant DA neuronal dynamics in PD brains.
Keywords: Parkinson’s disease (PD), p38MAPK, PI3K/AKT, neuroinflammation, oxidative stress (OS), apoptosis, neurotherapeutics
Full-Text [PDF 286 kb]   (2525 Downloads)    
Type of Study: Review | Subject: Medical Pharmacology
Received: 2014/12/10 | Accepted: 2015/01/3 | Published: 2015/03/14
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA code


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Jha S K, Jha N K, Kar R, Ambasta R K, Kumar P. p38 MAPK and PI3K/AKT signalling cascades in Parkinson’s disease. Int J Mol Cell Med. 2015; 4 (2) :67-86
URL: http://ijmcmed.org/article-1-267-en.html


Volume 4, Issue 2 (Int J Mol Cell Med 2015) Back to browse issues page
International Journal of Molecular and Cellular Medicine (IJMCM) International Journal of Molecular and Cellular Medicine (IJMCM)
Persian site map - English site map - Created in 0.05 seconds with 31 queries by YEKTAWEB 3781